Acute Angioedema Triggered by Daptomycin

Valentin Gisler1, Sabine Müller2, Lionel Müller3

  • 1Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.

Abstract

Insights

Daptomycin, an antibiotic for Staphylococcus aureus infections, can rarely cause acute angioedema, a serious allergic reaction. This case highlights the potential for immediate-type hypersensitivity to daptomycin, even on initial exposure.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Allergy and Immunology

Background:

  • Daptomycin is a cyclic lipopeptide antibiotic commonly used for Staphylococcus aureus bloodstream infections.
  • While generally safe, serious adverse events are rare.
  • This report details a case of acute angioedema potentially triggered by daptomycin.

Purpose of the Study:

  • To report a rare case of acute angioedema induced by daptomycin.
  • To raise awareness among clinicians about immediate-type hypersensitivity reactions to daptomycin.

Main Methods:

  • A 60-year-old female patient with persistent S. aureus bacteremia and acute kidney injury was treated with daptomycin and ceftriaxone.
  • The patient developed acute angioedema (lip and tongue swelling, dyspnea) shortly after the first daptomycin dose.
  • An intradermal skin test confirmed hypersensitivity to daptomycin.

Main Results:

  • The patient experienced acute angioedema following daptomycin administration.
  • Switching to vancomycin led to a favorable clinical outcome.
  • Intradermal testing showed a positive reaction to daptomycin and a negative reaction to ceftriaxone.

Conclusions:

  • Daptomycin was identified as the probable or certain cause of acute angioedema in this patient.
  • Clinicians should consider daptomycin as a potential cause of immediate-type hypersensitivity reactions, including angioedema, even with initial use.

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
126
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
22
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
142
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K